Secondary Parkinsonism Latest Advances

Find the Latest Research About Secondary Parkinsonism

Last Updated: 02/24/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 7113 publications

Cerebral Perfusion and Motor Deficits in Drug-Induced Parkinsonism: A Dual-Phase 18F-FP-CIT PET Study.

Cerebral Perfusion and Motor Deficits in Drug-Induced Parkinsonism: A Dual-Phase 18F-FP-CIT PET Study.

Journal: Neurology
Published: January 09, 2026

Drug-Induced Parkinsonism: A Structured, Mechanism-Informed Approach to Identification and Management.

Drug-Induced Parkinsonism: A Structured, Mechanism-Informed Approach to Identification and Management.

Journal: Cureus
Published: October 19, 2025

Neuroprotective Effects of Intranasally Administered Octadecaneuropeptide Analog in a Mouse Model of MPTP-Induced Parkinson's Disease.

Neuroprotective Effects of Intranasally Administered Octadecaneuropeptide Analog in a Mouse Model of MPTP-Induced Parkinson's Disease.

Journal: Journal of visualized experiments : JoVE
Published: September 15, 2025

RRx-001 ameliorates astrocyte pyroptosis by regulating LCN2-NLRP3 inflammasome activation in an MPTP-induced parkinson's disease mouse model.

RRx-001 ameliorates astrocyte pyroptosis by regulating LCN2-NLRP3 inflammasome activation in an MPTP-induced parkinson's disease mouse model.

Journal: Cellular and molecular life sciences : CMLS
Published: August 30, 2025

Neuroprotective impacts of taurine nanoparticles against rotenone induced Parkinson's disease in mice.

Neuroprotective impacts of taurine nanoparticles against rotenone induced Parkinson's disease in mice.

Journal: Toxicology mechanisms and methods
Published: August 14, 2025

Assessment of the Behavioral and Neurochemical Characteristics in a Mice Model of the Premotor Stage of Parkinson's Disease Induced by Chronic Administration of a Low Dose of MPTP.

Assessment of the Behavioral and Neurochemical Characteristics in a Mice Model of the Premotor Stage of Parkinson's Disease Induced by Chronic Administration of a Low Dose of MPTP.

Journal: International journal of molecular sciences
Published: August 01, 2025

Pharmacological profiling of Thiamet-G inhibitor in MPTP induced Parkinson's disease: Evidence from behavioral, biochemical, and histological studies.

Pharmacological profiling of Thiamet-G inhibitor in MPTP induced Parkinson's disease: Evidence from behavioral, biochemical, and histological studies.

Journal: Behavioural brain research
Published: July 24, 2025

Delayed emergence of parkinson's disease after reversible manganese-induced parkinsonism: a case report.

Delayed emergence of parkinson's disease after reversible manganese-induced parkinsonism: a case report.

Journal: BMC neurology
Published: July 24, 2025

PROTECTIVE EFFECTS OF CURCUMA LONGA IN A ROTENONE-INDUCED RAT MODEL OF PARKINSON'S DISEASE: ELECTROPHYSIOLOGICAL AND BEHAVIORAL EVIDENCE.

PROTECTIVE EFFECTS OF CURCUMA LONGA IN A ROTENONE-INDUCED RAT MODEL OF PARKINSON'S DISEASE: ELECTROPHYSIOLOGICAL AND BEHAVIORAL EVIDENCE.

Journal: Georgian medical news
Published: July 22, 2025

Movement-related activity in the internal globus pallidus of the parkinsonian macaque.

Movement-related activity in the internal globus pallidus of the parkinsonian macaque.

Journal: Journal of neurophysiology
Published: July 22, 2025

The role of presynaptic dopaminergic imaging in acquired neurological conditions affecting basal ganglia: a systematic review.

The role of presynaptic dopaminergic imaging in acquired neurological conditions affecting basal ganglia: a systematic review.

Journal: Frontiers in neurology
Published: July 06, 2025

Therapeutic Effect of Physical Activity in a Male Wistar Rat Model of Paraquat and Maneb-Induced Parkinson's Disease.

Therapeutic Effect of Physical Activity in a Male Wistar Rat Model of Paraquat and Maneb-Induced Parkinson's Disease.

Journal: Neurochemical research
Published: July 03, 2025
Showing 1-12 of 7,113

Last Updated: 02/24/2026